Search - tctmd.com

Displaying 661 - 680 of 742

Sort: Relevancy | Date

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Daily News

Readmission Rate After Carotid Revascularization an Opportunity for Improvement

April 06, 2015

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

News Conference News ACC 2015

Coronary CTA Fails to Live Up to Its PROMISE in Suspected CAD

L.A. McKeown

March 14, 2015

News Daily News

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

L.A. McKeown

February 19, 2015

News Daily News

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

January 28, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

News Daily News

Age Matters in Acute Stroke Patients Treated With Stent Retriever

November 17, 2014

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Daily News

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Yael L. Maxwell

September 02, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

News Daily News

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Caitlin E. Cox

June 13, 2014

News Daily News

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

L.A. McKeown

June 03, 2014

News Industry News

Boston Scientific Joins Optum Labs as Founding Medical Device Partner

May 06, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

Advertisement

Silent A-fib After Acute MI Portends Poor Outcome

Readmission Rate After Carotid Revascularization an Opportunity for Improvement

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

Coronary CTA Fails to Live Up to Its PROMISE in Suspected CAD

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Age Matters in Acute Stroke Patients Treated With Stent Retriever

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

Boston Scientific Joins Optum Labs as Founding Medical Device Partner

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content